Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon.

The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th-8th February 2019 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Learn from 20+ industry leading speakers who will be sharing their presentations and use cases on Non-invasive diagnosis of lung cancer, disruptive technologies in biomarker research, Next-generation CAR T-cells, Cloud software solutions for Clinical assays experiences.

Facilitated networking sessions to ensure quality interactions which include one on one query handling by biomarker experts and the opportunity to develop long-lasting business relationships and networking opportunities with senior peers.

Latest updates on regulatory guidelines and approvals, NGS and novel technologies in biomarker discovery, Commercialization of biomarkers in therapeutic and CDx applications with senior leaders from the Biomarker Industry.